Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates
GlobeNewswire, Inc.
ZURICH, SWITZERLAND, July 29, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today provided an update on its core patent portfolio.
Blood Collection Tubes Market Research Reveals Strong 8.9% CAGR Outlook Through 2030
EIN Presswire
The Business Research Company's Blood Collection Tubes Market Research Reveals Strong 8.9% CAGR Outlook Through 2030 LONDON, GREATER LONDON, UNITED KINGDOM, July 29, 2026 /EINPresswire.com/ -- "The blood collection tubes market has been...
Kiteworks Survey Finds Middle East Compliance Consequence Rate Hits 76%, Highest of Any Region
EIN Presswire
Just 7% of Middle East Organizations Rank AI Regulation Their Top Compliance Concern, Lowest of Any Region ZURICH, ZüRICH, SWITZERLAND, July 29, 2026 /EINPresswire.com/ -- Kiteworks, which empowers organizations to effectively manage risk in...
Stand Up for Science Announces International Non-Profit Expansion to Protect Science on a Global Scale
EIN Presswire
SUFS International will build on the group’s momentum to promote evidence-based policy making and support pro-science movements around the world.
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
GlobeNewswire, Inc.
ZURICH, SWITZERLAND, July 27, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, today announced the advancement of bispecific ADC (bsADC) program VXA-222, following...
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
GlobeNewswire, Inc.
ZURICH, SWITZERLAND , July 24, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in the design and development of next-generation cancer therapeutics, held an Extraordinary General Meeting (EGM) today.
Engineered Wood Market to Surpass $521 Billion by 2035 as Mass-Timber Codes and Carbon Accounting Reshape Construction
EIN Presswire
North America is advancing at a 6.75% CAGR through 2035, reflecting policy-driven tall-wood adoption across the United States and Canada.
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio
GlobeNewswire, Inc.
ZURICH, SWITZERLAND, July 23, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Christoph Erkel, Ph.D., as Chief Scientific Officer...
Physical AI Requires Quantum-Safe Chips Today; SEALSQ Common Criteria Certification Will Strengthen Trust for Tomorrow
GlobeNewswire, Inc.
Geneva, Switzerland, July 29, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today...
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
GlobeNewswire, Inc.
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing.
FX Junction Releases Research on the Role of Social Media Presence in Stock Intrinsic Value
GlobeNewswire, Inc.
FOMBONI, Comoros Union, July 23, 2026 (GLOBE NEWSWIRE) -- New analysis finds that for a growing class of "social-media-native" equities, the communication channel itself — not just the information it carries — is shaping how the market prices the...
8lends and Cointelegraph Research release report on addressing Europe’s €39B SME funding gap with onchain private credit
GlobeNewswire, Inc.
DUBAI, United Arab Emirates, July 22, 2026 (GLOBE NEWSWIRE) -- Cointelegraph Research and 8lends have released a joint study on the estimated €39 billion annual funding gap facing small and medium-sized enterprises across Europe.
csprUSD Launching as Casper's Standard Stablecoin, Rebuilt for the Machine Economy
EIN Presswire
Upgraded for Casper 2.0 and x402 micropayments, csprUSD becomes the settlement currency for AI agents transacting on Casper Network.
Protein Design And Engineering Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight
EIN Presswire
The Business Research Company's Protein Design And Engineering Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, July 21, 2026 /EINPresswire.com/ -- "The protein design and...
Funkled and Focus Partner to Turn Financial Education into Advice-Ready Clients
GlobeNewswire, Inc.
YORK, United Kingdom and LEAMINGTON SPA, United Kingdom, July 29, 2026 (GLOBE NEWSWIRE) -- Financial education platform Funkled has partnered with Focus, the UK advice technology provider, to combine free, jargon-free financial education with...
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the...
Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
GlobeNewswire, Inc.
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 29, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and...
Cytosurge elects veteran biotech executive, investor, and company builder Luba Greenwood, J.D., to its Board of Directors
GlobeNewswire, Inc.
Luba Greenwood joins Cytosurge’s Board of Directors to support the company’s next phase of commercial growth and scientific progress as Cytosurge builds the causal data foundation for AI-driven drug discovery.
Constellium Reports Strong Second Quarter and First Half 2026 Results, including Record Segment Adjusted EBITDA; Raises Full Year 2026 Guidance
GlobeNewswire, Inc.
PARIS, July 29, 2026 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) ("Constellium" or the "Company") today reported results for the second quarter and the first half ended June 30, 2026. Second quarter 2026 highlights: Shipments of 381 thousand...
Free Platform Launches Daily Money Lessons to Boost Britain's Financial Confidence
GlobeNewswire, Inc.
YORK, United Kingdom, July 29, 2026 (GLOBE NEWSWIRE) -- A new free platform launches this week, offering a month of daily lessons designed to be simple enough to complete, plus free tools people can use straight away.
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.